Abstract:Abstract Krüppel-like factor 5 (KLF5) is an evolutionarily conserved zinc finger-containing transcription factor promoting breast cell proliferation, survival, and tumor growth through upregulating its target gene FGF-BP. The protein abundance of KLF5 has been shown to be strictly regulated at transcriptional and posttranslational levels. Our previous studies suggest that the KLF5 protein degradation is through the ubiquitin proteasome pathway. The WWP1 E3 ligase can target KLF5 for ubiquitin-mediated proteasomal degradation. In this study, we demonstrated the F-box protein FBW7 targets KLF5 for proteolysis and suppresses KLF5's functions in breast cancer. The SCFFBW7 (SKP1-Cullin1-F-box) E3 ligase complex has been shown to target several oncoproteins, including MYC and CyclinE, for proteolysis. FBW7 could be a tumor suppressor due to its frequent mutations in multiple cancers. Here, we first demonstrated that inactivation of endogenous FBW7 by gene knockout, knockdown, or mutation remarkably increases the endogenous KLF5 protein abundances through blocking its degradation in multiple cell lines. Second, we found that overexpression of FBW7 decreases the exogenous and endogenous KLF5 protein levels in HEK293T and SUM149PT cell lines. Functionally, overexpression of FBW7 in the endogenous FBW7 mutated SUM149PT cells decreases the FGF-BP gene expression and the DNA synthesis. Importantly, knockdown of endogenous Fbw7 increases the FGF-BP gene expression, cell proliferation, and survival through upregulating the KLF5 expression in breast cells. These findings suggest that the Fbw7 tumor suppressor inhibit breast cancer cell proliferation and survival at least partially through targeting KLF5 for ubiquitin-mediated degradation. This new regulatory mechanism of KLF5 degradation may result in useful diagnostic and therapeutic targets for breast cancer and other cancers. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3155.

The Fbw7 Tumor Suppressor Targets Klf5 For Ubiquitin-Mediated Degradation And Suppresses Breast Cell Proliferation

Abstract 3155: the SCFFBW7 E3 Ubiquitin Ligase Targets Krüppel-like Factor 5 (KLF5) for Proteolysis in Breast Cancer

The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs

The Scffbw7 E3 Ubiquitin Ligase Complex Targets Klf5 For Ubiquitination And Degradation In A Phosphorylation Dependent Manner

FBW7-mediated ubiquitination and degradation of KLF5.

FBW7 Suppresses Cell Proliferation and G2/M Cell Cycle Transition Via Promoting Γ-Catenin K63-linked Ubiquitylation.

Functional Characterization of FBXL7 As a Novel Player in Human Cancers

KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer

Emerging Roles of the FBW 7 Tumour Suppressor in Stem Cell Differentiation

Regulation of APC Cdh1 E3 Ligase Activity by the Fbw7/cyclin E Signaling Axis Contributes to the Tumor Suppressor Function of Fbw7

Krüppel-like Factor 5 Promotes Breast Cell Proliferation Partially Through Upregulating the Transcription of Fibroblast Growth Factor Binding Protein 1.

The Fbw7 Tumor Suppressor Regulates Glycogen Synthase Kinase 3 Phosphorylation-Dependent C-Myc Protein Degradation

KLF5 Promotes Breast Cell Survival Partially Through Fibroblast Growth Factor-Binding Protein 1-Perk-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization.

SCF FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.

ERK Kinase Phosphorylates and Destabilizes the Tumor Suppressor FBW7 in Pancreatic Cancer.

Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation

Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.

Loss of the Fbw7 tumor suppressor rewires cholesterol metabolism in cancer cells leading to activation of the PI3K-AKT signalling axis

Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations

The FBW7-KLF2 Axis Regulates Endothelial Functions